Mytide Therapeutics is committed to providing peptides to serve a diverse array of applications.
Mytide is committed to providing peptides to serve a diverse array of applications. They intend to work closely with partners to overcome challenges in synthesizing and purifying particular classes of peptides of interest, identify useful peptide modifications, and design and construct peptide libraries. They provide initial partners access to their cloud platform for immediate ordering, properties calculator, order tracking, and interactive data display.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 8, 2022 | Series A | $7M | 1 | Alloy Therapeutics | — | Detail |
Dec 13, 2019 | Grant | $269.96K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Alloy Therapeutics | Yes | Series A |
National Science Foundation | Yes | Grant |